longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Atlantic

ATLN

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.89, within the reasonable range, cheaper than 33.33% of the time in the past 1 years, and the industry ranks 27/59, the industry Median -1.52.

-0.895xP/E
--Stock price
-0.895xP/E
Stock price--

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-1.53x
Typical range
-2.11x–-0.89x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
LZAGYUSLonza
-349.81x--$48.21B
TEMUSTempus AI
-57.99x1.23%$14.75B
CRLUSCharles River Laboratorie
-58.95x215.72%$14.06B
TXGUS10X Genomics
-145.87x107.32%$10.96B
AVTRUSAvantor
-18.00x142.83%$10.40B
BRKRUSBruker
-91.22x7.71%$9.75B
ADPTUSAdaptive Biotechnologies
-73.91x39.98%$4.72B
ABCLUSAbcellera Biologics
-24.90x34.69%$4.10B
ALMRUSAlamar Biosciences
-46.39x80.55%$2.30B
MRVIUSMaravai LifeSciences
-25.67x65.83%$1.99B
FTREUSFortrea
-22.35x93.77%$1.90B
PSNLUSPersonalis
-16.51x20.05%$1.77B
AZTAUSAzenta
-12.19x180.77%$1.50B
CYRXUSCryoport
-19.42x156.25%$881.29M
CTKBUSCytek Biosciences
-9.24x33.98%$744.80M
OABIUSOmniAb
-15.73x35.96%$696.42M
DNAUSGinkgo Bioworks
-2.37x35.20%$690.24M
EVOUSEvotec SE
-2.38x381.02%$543.47M
TKNOUSAlpha Teknova
-29.74x5.80%$498.76M
PACBUSPacific Biosc California
-3.74x75.82%$491.11M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.